Equillium, Inc. SEC filings EQ

Equillium, Inc. has 465 filings in SEC EDGAR's recent list, going back to Aug 3, 2018. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (unregistered share sale, regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Equillium, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 4, 2026 —
8-K Current report
Unregistered share sale, Regulation FD disclosure, Other events
Oct 26, 2026 Oct 26, 2026
8-K Current report
Other events
Oct 5, 2026 Oct 5, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2026 —
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2026 —
144 Notice of proposed sale Jun 5, 2026 —
4 Insider transaction Jun 5, 2026 Jun 5, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
144 Notice of proposed sale Jun 4, 2026 —
4 Insider transaction May 29, 2026 May 28, 2026
4 Insider transaction May 29, 2026 May 28, 2026
4 Insider transaction May 29, 2026 May 28, 2026
4 Insider transaction May 29, 2026 May 28, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 28, 2026
4 Insider transaction May 29, 2026 May 28, 2026
8-K Current report
Shareholder vote results
May 29, 2026 May 28, 2026
144 Notice of proposed sale May 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
SCHEDULE 13G Ownership over 5% (passive) May 7, 2026 —
EFFECT Filing Apr 16, 2026 —
ARS Annual report to shareholders Apr 15, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 15, 2026 —
DEF 14A Proxy statement Apr 15, 2026 May 28, 2026
CORRESP Letter to the SEC Apr 14, 2026 —
UPLOAD Letter from the SEC Apr 13, 2026 —
S-3 Shelf registration Apr 7, 2026 —
PRE 14A Preliminary proxy statement Mar 30, 2026 May 28, 2026
EFFECT Filing Mar 25, 2026 —
S-8 Employee stock plan registration Mar 25, 2026 —
10-K Annual report Mar 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 25, 2026 Mar 25, 2026
CORRESP Letter to the SEC Mar 23, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 20, 2026 —
4 Insider transaction Mar 16, 2026 Mar 13, 2026
144 Notice of proposed sale Mar 13, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Mar 13, 2026 Mar 11, 2026
4/A Filing Mar 11, 2026 Feb 19, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
144 Notice of proposed sale Mar 9, 2026 —
4 Insider transaction Feb 23, 2026 Feb 19, 2026
144 Notice of proposed sale Feb 19, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 6, 2026 —
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
144 Notice of proposed sale Jan 8, 2026 —
4 Insider transaction Dec 23, 2025 Dec 23, 2025
144 Notice of proposed sale Dec 23, 2025 —
4 Insider transaction Dec 15, 2025 Dec 12, 2025
144 Notice of proposed sale Dec 12, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 8, 2025 —
4 Insider transaction Nov 25, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
S-3 Shelf registration Nov 13, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 13, 2025 —
8-K/A Amended current report
Auditor change
Oct 24, 2025 Sep 30, 2025
8-K Current report
Auditor change, Officer or director change, Other events
Oct 6, 2025 Sep 30, 2025
8-K Current report
Other events
Sep 19, 2025 Sep 19, 2025
424B5 Prospectus supplement Sep 19, 2025 —
EFFECT Filing Sep 18, 2025 —
CORRESP Letter to the SEC Sep 16, 2025 —
UPLOAD Letter from the SEC Sep 16, 2025 —
UPLOAD Letter from the SEC Sep 11, 2025 —
CORRESP Letter to the SEC Sep 11, 2025 —
S-8 Employee stock plan registration Sep 9, 2025 —
S-3 Shelf registration Sep 9, 2025 —
UPLOAD Letter from the SEC Sep 8, 2025 —
8-K Current report
Other events
Sep 4, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 11, 2025 Aug 10, 2025
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
Aug 4, 2025 Aug 3, 2025
144 Notice of proposed sale Jul 8, 2025 —
8-K Current report
Listing notice
Jun 13, 2025 Jun 12, 2025
144 Notice of proposed sale Jun 12, 2025 —
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 22, 2025 May 21, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
DEFR14A Filing Apr 30, 2025 —
8-K Current report
Results of operations
Apr 24, 2025 Apr 24, 2025
ARS Annual report to shareholders Apr 10, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 10, 2025 —
DEF 14A Proxy statement Apr 10, 2025 May 21, 2025
PRE 14A Preliminary proxy statement Mar 28, 2025 May 21, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
8-K Current report
Other events
Feb 6, 2025 Feb 6, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
8-K Current report
Listing notice
Dec 13, 2024 Dec 13, 2024
4 Insider transaction Dec 12, 2024 Dec 11, 2024
3 Initial insider ownership Dec 12, 2024 Dec 11, 2024
8-K Current report
Officer or director change
Dec 12, 2024 Dec 10, 2024
4 Insider transaction Nov 15, 2024 Nov 14, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
144 Notice of proposed sale Nov 14, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
144 Notice of proposed sale Oct 31, 2024 —
8-K Current report
Other events
Oct 31, 2024 Oct 30, 2024
8-K Current report
Other events
Oct 31, 2024 Oct 30, 2024
4 Insider transaction Oct 30, 2024 Oct 28, 2024
4 Insider transaction Oct 29, 2024 Oct 25, 2024
4 Insider transaction Sep 27, 2024 Sep 26, 2024
4 Insider transaction Sep 17, 2024 Sep 16, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Listing notice
Jul 23, 2024 Jul 19, 2024
4 Insider transaction Jul 18, 2024 Jul 16, 2024
8-K Current report
Results of operations
Jul 18, 2024 Jul 18, 2024
144 Notice of proposed sale Jul 16, 2024 —
8-K Current report
Other events
Jun 4, 2024 Jun 4, 2024
4 Insider transaction May 23, 2024 May 22, 2024
4 Insider transaction May 23, 2024 May 22, 2024
4 Insider transaction May 23, 2024 May 22, 2024
4 Insider transaction May 23, 2024 May 22, 2024
4 Insider transaction May 23, 2024 May 22, 2024
4 Insider transaction May 23, 2024 May 22, 2024
8-K Current report
Shareholder vote results
May 23, 2024 May 22, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 11, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 11, 2024 —
DEF 14A Proxy statement Apr 11, 2024 May 22, 2024
PRE 14A Preliminary proxy statement Apr 1, 2024 May 22, 2024
8-K Current report
Other events
Apr 1, 2024 Apr 1, 2024
S-8 Employee stock plan registration Mar 25, 2024 —
10-K Annual report Mar 25, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 25, 2024 Mar 25, 2024
3 Initial insider ownership Mar 8, 2024 Mar 6, 2024
8-K Current report
Officer or director change, Other events
Mar 8, 2024 Mar 6, 2024
8-K Current report
Results of operations, Other events
Feb 23, 2024 Feb 23, 2024
424B5 Prospectus supplement Feb 23, 2024 —
8-K Current report
Other events
Feb 22, 2024 Feb 21, 2024
SC 13G Ownership over 5% (passive) Jan 19, 2024 —
4 Insider transaction Jan 3, 2024 Jan 2, 2024
4 Insider transaction Jan 3, 2024 Jan 2, 2024
4 Insider transaction Jan 3, 2024 Jan 2, 2024
4 Insider transaction Jan 3, 2024 Jan 2, 2024
4 Insider transaction Jan 3, 2024 Jan 2, 2024
4 Insider transaction Jan 3, 2024 Jan 2, 2024
8-K Current report
Other events
Dec 21, 2023 Dec 21, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations, Other events
Nov 8, 2023 Nov 6, 2023
8-K Current report
Regulation FD disclosure, Other events
Oct 16, 2023 Oct 16, 2023
8-K Current report
Material agreement, Agreement ended, Listing notice
Oct 5, 2023 Oct 3, 2023
424B5 Prospectus supplement Oct 5, 2023 —
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Agreement ended
May 25, 2023 May 25, 2023
4 Insider transaction May 23, 2023 May 22, 2023
4 Insider transaction May 23, 2023 May 22, 2023
4 Insider transaction May 23, 2023 May 22, 2023
4 Insider transaction May 23, 2023 May 22, 2023
4 Insider transaction May 23, 2023 May 22, 2023
4 Insider transaction May 23, 2023 May 22, 2023
8-K Current report
Shareholder vote results
May 23, 2023 May 22, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
ARS Annual report to shareholders Apr 13, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 13, 2023 —
DEF 14A Proxy statement Apr 11, 2023 May 22, 2023
8-K Current report
Listing notice
Apr 6, 2023 Apr 5, 2023
PRE 14A Preliminary proxy statement Mar 31, 2023 May 22, 2023
10-K Annual report Mar 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 23, 2023 Mar 23, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EQ (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
La Jolla, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1746466

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.